Report Detail
Global Anti-Obesity Therapeutics Market Professional Survey Report 2019
- RnM3766344 |
- 20 September, 2019 |
- Global |
- 110 Pages |
- QYResearch |
- Pharma & Healthcare
Anti-obesity drugs are the drugs that help in reducing or controlling body mass, either by decreasing the craving or increasing the consumption of calories. Appetite control is achieved through the use of agonists for appetite suppressing pathways.
Geographically, North America captures the largest market share on account of increasing obese population. As per the historical trends, more than one-third of the U.S. population is obese. However, Asia Pacific is anticipated to grow at the fastest rate due to increasing demand for the drugs and awareness about the risk associated with obesity. According to WHO, 13.0% of the population were obese in 2014. In developing countries the rate of childhood obesity is increasing and has been 30.0% higher than that of developed countries.
The global Anti-Obesity Therapeutics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Anti-Obesity Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anti-Obesity Therapeutics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Anti-Obesity Therapeutics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Anti-Obesity Therapeutics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Bristol-Myers Squibb
Eisai Company
FlaxoSithKline plc.
Novo Nordisk
Alizyme
BoehringerIngelheim GmbH
Pfizer
Takeda Pharmaceutical
Rhythm Pharmaceuticals
Shionogi USA
Vivus
Zafgen
Norgine Pharmaceuticals Ltd.
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Centrally Acting Anti-obesity Drugs
Peripherally Acting Anti-obesity Drugs
Segment by Application
Hospital Use
Clinic Use
Household
Other
Table of Contents
Executive Summary
1 Industry Overview of Anti-Obesity Therapeutics
- 1.1 Definition of Anti-Obesity Therapeutics
- 1.2 Anti-Obesity Therapeutics Segment by Type
- 1.2.1 Global Anti-Obesity Therapeutics Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Centrally Acting Anti-obesity Drugs
- 1.2.3 Peripherally Acting Anti-obesity Drugs
- 1.3 Anti-Obesity Therapeutics Segment by Applications
- 1.3.1 Global Anti-Obesity Therapeutics Consumption Comparison by Applications (2014-2025)
- 1.3.2 Hospital Use
- 1.3.3 Clinic Use
- 1.3.4 Household
- 1.3.5 Other
- 1.4 Global Anti-Obesity Therapeutics Overall Market
- 1.4.1 Global Anti-Obesity Therapeutics Revenue (2014-2025)
- 1.4.2 Global Anti-Obesity Therapeutics Production (2014-2025)
- 1.4.3 North America Anti-Obesity Therapeutics Status and Prospect (2014-2025)
- 1.4.4 Europe Anti-Obesity Therapeutics Status and Prospect (2014-2025)
- 1.4.5 China Anti-Obesity Therapeutics Status and Prospect (2014-2025)
- 1.4.6 Japan Anti-Obesity Therapeutics Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Anti-Obesity Therapeutics Status and Prospect (2014-2025)
- 1.4.8 India Anti-Obesity Therapeutics Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Anti-Obesity Therapeutics
- 2.3 Manufacturing Process Analysis of Anti-Obesity Therapeutics
- 2.4 Industry Chain Structure of Anti-Obesity Therapeutics
3 Development and Manufacturing Plants Analysis of Anti-Obesity Therapeutics
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Anti-Obesity Therapeutics Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Anti-Obesity Therapeutics
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Anti-Obesity Therapeutics Production and Capacity Analysis
- 4.2 Anti-Obesity Therapeutics Revenue Analysis
- 4.3 Anti-Obesity Therapeutics Price Analysis
- 4.4 Market Concentration Degree
5 Anti-Obesity Therapeutics Regional Market Analysis
- 5.1 Anti-Obesity Therapeutics Production by Regions
- 5.1.1 Global Anti-Obesity Therapeutics Production by Regions
- 5.1.2 Global Anti-Obesity Therapeutics Revenue by Regions
- 5.2 Anti-Obesity Therapeutics Consumption by Regions
- 5.3 North America Anti-Obesity Therapeutics Market Analysis
- 5.3.1 North America Anti-Obesity Therapeutics Production
- 5.3.2 North America Anti-Obesity Therapeutics Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Anti-Obesity Therapeutics Import and Export
- 5.4 Europe Anti-Obesity Therapeutics Market Analysis
- 5.4.1 Europe Anti-Obesity Therapeutics Production
- 5.4.2 Europe Anti-Obesity Therapeutics Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Anti-Obesity Therapeutics Import and Export
- 5.5 China Anti-Obesity Therapeutics Market Analysis
- 5.5.1 China Anti-Obesity Therapeutics Production
- 5.5.2 China Anti-Obesity Therapeutics Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Anti-Obesity Therapeutics Import and Export
- 5.6 Japan Anti-Obesity Therapeutics Market Analysis
- 5.6.1 Japan Anti-Obesity Therapeutics Production
- 5.6.2 Japan Anti-Obesity Therapeutics Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Anti-Obesity Therapeutics Import and Export
- 5.7 Southeast Asia Anti-Obesity Therapeutics Market Analysis
- 5.7.1 Southeast Asia Anti-Obesity Therapeutics Production
- 5.7.2 Southeast Asia Anti-Obesity Therapeutics Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Anti-Obesity Therapeutics Import and Export
- 5.8 India Anti-Obesity Therapeutics Market Analysis
- 5.8.1 India Anti-Obesity Therapeutics Production
- 5.8.2 India Anti-Obesity Therapeutics Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Anti-Obesity Therapeutics Import and Export
6 Anti-Obesity Therapeutics Segment Market Analysis (by Type)
- 6.1 Global Anti-Obesity Therapeutics Production by Type
- 6.2 Global Anti-Obesity Therapeutics Revenue by Type
- 6.3 Anti-Obesity Therapeutics Price by Type
7 Anti-Obesity Therapeutics Segment Market Analysis (by Application)
- 7.1 Global Anti-Obesity Therapeutics Consumption by Application
- 7.2 Global Anti-Obesity Therapeutics Consumption Market Share by Application (2014-2019)
8 Anti-Obesity Therapeutics Major Manufacturers Analysis
- 8.1 Bristol-Myers Squibb
- 8.1.1 Bristol-Myers Squibb Anti-Obesity Therapeutics Production Sites and Area Served
- 8.1.2 Bristol-Myers Squibb Product Introduction, Application and Specification
- 8.1.3 Bristol-Myers Squibb Anti-Obesity Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Eisai Company
- 8.2.1 Eisai Company Anti-Obesity Therapeutics Production Sites and Area Served
- 8.2.2 Eisai Company Product Introduction, Application and Specification
- 8.2.3 Eisai Company Anti-Obesity Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 FlaxoSithKline plc.
- 8.3.1 FlaxoSithKline plc. Anti-Obesity Therapeutics Production Sites and Area Served
- 8.3.2 FlaxoSithKline plc. Product Introduction, Application and Specification
- 8.3.3 FlaxoSithKline plc. Anti-Obesity Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Novo Nordisk
- 8.4.1 Novo Nordisk Anti-Obesity Therapeutics Production Sites and Area Served
- 8.4.2 Novo Nordisk Product Introduction, Application and Specification
- 8.4.3 Novo Nordisk Anti-Obesity Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Alizyme
- 8.5.1 Alizyme Anti-Obesity Therapeutics Production Sites and Area Served
- 8.5.2 Alizyme Product Introduction, Application and Specification
- 8.5.3 Alizyme Anti-Obesity Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 BoehringerIngelheim GmbH
- 8.6.1 BoehringerIngelheim GmbH Anti-Obesity Therapeutics Production Sites and Area Served
- 8.6.2 BoehringerIngelheim GmbH Product Introduction, Application and Specification
- 8.6.3 BoehringerIngelheim GmbH Anti-Obesity Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Pfizer
- 8.7.1 Pfizer Anti-Obesity Therapeutics Production Sites and Area Served
- 8.7.2 Pfizer Product Introduction, Application and Specification
- 8.7.3 Pfizer Anti-Obesity Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Takeda Pharmaceutical
- 8.8.1 Takeda Pharmaceutical Anti-Obesity Therapeutics Production Sites and Area Served
- 8.8.2 Takeda Pharmaceutical Product Introduction, Application and Specification
- 8.8.3 Takeda Pharmaceutical Anti-Obesity Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Rhythm Pharmaceuticals
- 8.9.1 Rhythm Pharmaceuticals Anti-Obesity Therapeutics Production Sites and Area Served
- 8.9.2 Rhythm Pharmaceuticals Product Introduction, Application and Specification
- 8.9.3 Rhythm Pharmaceuticals Anti-Obesity Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Shionogi USA
- 8.10.1 Shionogi USA Anti-Obesity Therapeutics Production Sites and Area Served
- 8.10.2 Shionogi USA Product Introduction, Application and Specification
- 8.10.3 Shionogi USA Anti-Obesity Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 Vivus
- 8.12 Zafgen
- 8.13 Norgine Pharmaceuticals Ltd.
9 Development Trend of Analysis of Anti-Obesity Therapeutics Market
- 9.1 Global Anti-Obesity Therapeutics Market Trend Analysis
- 9.1.1 Global Anti-Obesity Therapeutics Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Anti-Obesity Therapeutics Regional Market Trend
- 9.2.1 North America Anti-Obesity Therapeutics Forecast 2019-2025
- 9.2.2 Europe Anti-Obesity Therapeutics Forecast 2019-2025
- 9.2.3 China Anti-Obesity Therapeutics Forecast 2019-2025
- 9.2.4 Japan Anti-Obesity Therapeutics Forecast 2019-2025
- 9.2.5 Southeast Asia Anti-Obesity Therapeutics Forecast 2019-2025
- 9.2.6 India Anti-Obesity Therapeutics Forecast 2019-2025
- 9.3 Anti-Obesity Therapeutics Market Trend (Product Type)
- 9.4 Anti-Obesity Therapeutics Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Anti-Obesity Therapeutics Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Anti-Obesity Therapeutics. Industry analysis & Market Report on Anti-Obesity Therapeutics is a syndicated market report, published as Global Anti-Obesity Therapeutics Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Anti-Obesity Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
